chrisvoncsefalvay/vaers-outcomes huggingface dataset:
there was some weird feeling from my elbow to my wrist; kind of felt light; arm started shaking a little; it was kind of shaking like I couldn't control it just shook; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), in Jul2022 as dose 4 (booster), single (Lot number: EN6205) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 3 (BOOSTER), SINGLE, MANUFACTURER UNKNOWN, LOT UNKNOWN), for Covid-19 Immunization; Covid-19 vaccine (PRIMARY IMMUNIZATION SERIES COMPLETED, MANUFACTURER UNKNOWN, LOT UNKNOWN), for Covid-19 Immunization. The following information was reported: TREMOR (non-serious) with onset 30Jul2022, outcome "unknown", described as "arm started shaking a little; it was kind of shaking like I couldn't control it just shook"; FEELING ABNORMAL (non-serious) with onset 30Jul2022, outcome "unknown", described as "there was some weird feeling from my elbow to my wrist; kind of felt light".  Additional information: It was reported that, the patient was just wondering, after second booster shot last Saturday a week ago and then yesterday noticed there was some weird feeling from elbow to wrist and thought well, that was weird. It kind of felt light and everything else well then, last night it was like arm started shaking a little if that make sense, it kind of like where patient had the shot and stuff, it was kind of shaking like and could not control it just shook. So, did not know if that was a common, if that has happened before with the shot, it was not even a shot it may just be a coincidence but have never had anything like that before. Expiry Date of COVID-19 Vaccine was Unknown. Reason for no lot number of COVID-19 Vaccine: Other: It was stated, it looks like, it says EN6205. Yes, not the 5 patient think, hard to read the writing but yes think that was. Product details, Pharmacy details and other details could not be probed as consumer was unwilling to complete the report. Hence further probing could not be done. Limited information available over the call.  QR Comment: Reporter type could not be probed hence captured by default as Consumer or other non-health professional in tab.  No follow-up attempts are possible. No further information is expected.
Janssen COVID-19 Vaccine EUA  Extreme tiredness, headache, chills, loss of appetite
IBS flare; This spontaneous case was reported by a patient and describes the occurrence of IRRITABLE BOWEL SYNDROME (IBS flare) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced IRRITABLE BOWEL SYNDROME (IBS flare). At the time of the report, IRRITABLE BOWEL SYNDROME (IBS flare) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No  concomitant medication provided by the reporter. no treatment information provided by the reporter
The vaccine expiration date was identified to expire on June 22, 2021, but the manufacturer expiration date was February 25, 2021.  Based on the information learned, local Health took the following steps: ? Contacted Moderna for guidance and based on Moderna data, the Moderna Medical Information team provided the following information:  o ?The vaccine administered on March 4, 2021 through March 10, 2021 from lot number 025J20-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.?  ? Contacted a local medical director and based on this information from Moderna, no re-vaccination is needed.
residual leg pain; bilat leg stiffnes; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (residual leg pain) and MUSCULOSKELETAL STIFFNESS (bilat leg stiffnes) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (residual leg pain) and MUSCULOSKELETAL STIFFNESS (bilat leg stiffnes). At the time of the report, PAIN IN EXTREMITY (residual leg pain) and MUSCULOSKELETAL STIFFNESS (bilat leg stiffnes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information was not provided.  Treatment information was not provided.
Pt had childhood type breakout of measles. 3 days bed rest, Tylenol prescribed. A mass immunization of the live influenza mist was administered 6 days prior to patient visting clinic for MMR vaccine. Pt was unaware nasal influenza mist was a live virus and failed to notify vaccinator of receiving the flu mist on 12/12/06. He was then administered the live MMR vaccine on 12/18/06. (lot #0255F) Pt reported that 3 days following vaccination he visited a doctor on vacation and was diagnosed with childhood measles and put on bed rest for three days and given Tylenol for discomfort and fever.
2 y/o girl with hx of allergic rhinitis who was update inmunized yesterday who developed erythema, swelling and tenderness over left thigh area reason for which was brought for evaluation
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  3-year-old male patient received BNT162b2 (COMIRNATY), on 10Aug2022 at 15:35 as dose 1 (maroon cap), single (Lot number: FL2757) at the age of 3 years, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VOMITING (non-serious) with onset 10Aug2022 at 16:10, outcome "recovering". Additional information: First pediatric dose of Comirnaty administered at physician's office at 3:35pm. After 15 minute observation, we went to grocery store. While there, he seemed fine before suddenly vomiting at 4:10pm. He had no other symptoms before and has previously not had any adverse reactions to vaccines. It was reported that the pregnant and breastfeeding was no. It was reported as booster as no.
Tongue soreness (started on Jan 28, 2021 resolved same day), left arm urticaria (started Jan 28, 2021 and ongoing)
Felt dizzy, brief loss of consciousness, nausea and vomiting. Recovered after about 5 minutes.
Patient called our clinic on 01/10/19 at 1133am stating that on 01/09/19 he started having a small red pruritic rash over his face, back, trunk and arms. Denied fever and any other symptoms. Advised patient to call the doctor who prescribed him MMR and VZV vaccines to notify about the reaction and to have an assessment done. On 01/11/19 at 1600 the patient reported he was evaluated by Dr. and doctor said he had an allergic reaction and prescribed him a topical cream and some pills but he cannot recall the name. Per patient Dr. offered blood test but the patient declined due to lack of money since he doesn't have insurance.
Full body hives started roughly about 20-22 hours after injection. Ended up covering body within the coming days. Saw doctor virtually and prescribed prednisone  and two trips into the emergency room. ER administered epinephrine shot along with Benadryl, famotidine, and Ativan as the hives become in mouth and lips and swelling was occurring.
MODERNA COVID VACCINE #3 GIVEN 11/10/21, LOT #058F21A; Pt to ED via EMS with AMS and minimally responsive; O2 saturation 60% on RA; intubated on mechanical ventilation; admitted to ICU; septic shock; AHRF; ABX, steroids, remdesivir; family decided to withdraw care and pursue comfort measures; pt expired in the hospital
10 minutes after receiving vaccine pt started to have tingling down her left arm and left side of her face.  Vitals taken Pulse - 80, blood pressure 140/110. Pt state BP was very high for her.  Within 20 minutes of vaccination pt states tingling continued down are but started spreading across face and mouth began to tingle.  Emergency services called.
Headache, Fever, FATIGUE, CHILLS, NAUSEA, JOINT PAIN, INJECTION SITE PAIN Narrative:
Fever, Chills, Body Aches overall flu like symptoms for 24-48 hrs.
passed out; Golf ball sized knot from hitting head somehow, believes he passed out; Nauseous and sick; Dry heaves for 10-15 minutes; Nauseous and sick; A spontaneous report was received from a consumer concerning a 80-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events of loss of consciousness, haed injury,malaise, nauseous and retching, believes he passed out, dry heaves for 10-15 minutes, golf ball sized knot from hitting head.  The patient's medical history was not provided. Concomitant medications reported were blood pressure meds for drug use for an unknown indication.  On 5 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot number: 031L20A) via unknown route for prophylaxis of COVID-19 infection. On 10 Mar 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot number: 011A21A) via unknown route for prophylaxis of COVID-19 infection.  On 11 Mar 2021, the patient experienced the event(s)loss of consciousness, head injury, malaise, nauseous and retching, believes he passed out, dry heaves for 10-15 minutes, golf ball sized knot from hitting head.  Treatment information was unknown.  Action taken with mRNA-1273 in response to the events was not applicable.  On 12 Mar 2021 the outcome of event(s), nauseous and sick, believes he passed out, dry heaves for 10-15 minutes, golf ball sized knot from hitting head was considered as recovered/resolved..; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
October 1st I received the Shingrix vaccine. On October 6th i started feeling a burning sensation on my lower left back just above the waistline.  The burning sensation expanded over the next several days and by October 10th I had developed a rash on my lower left back just below the waistline. The rash grew rapidly over the next several days going around my left hip to my groin and lower pelvis and up to my stomach all in the lower left side of my torso.  On Monday October 12th I went to Clinic and there I was diagnosed with Shingles and given a prescription for Valtrex 1 gram tablet. On Thursday October 15th I had a visit with my primary doctor for an unrelated visit where he examined my rash and he did confirm the I had contracted Shingles.
Received Varicella vaccine at 12 months and 1 day of age on 3/29/2004.  Presented to the office on July 22, 2004 with Chicken Pox.  Confirmed by seconder provider.  Mild case, no fever.
02/11/2021 I started having a lot of pain in my right hip, the one I have a hip replacement in, that lasted 2 nights. I went to a local walk in clinic. After about 3 days the pain went away.
Administration of an expired dose; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 1-year-old female patient who received HAV (Havrix) (batch number y4fl4, expiry date 28th January 2022) for prophylaxis.   Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 1st February 2022, the patient received Havrix and Havrix Pre-Filled Syringe Device. On 1st February 2022, unknown after receiving Havrix and Havrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: An expired dose of Havrix was inadvertently administered to the patient, which led to expired vaccine used.  No further events were reported.  The reporter consented to follow up.  The Vaccine Administration Facility is the same as Primary Reporter. This case had been linked with case US2022022661, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022022661:Same reporter.
arm soreness; This is a spontaneous report from a contactable consumer or other non-HCP (patient, self-reporting). A 70-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EL9264 and expiration date was not reported), via an unspecified route of administration in left arm on 09Feb2021 14:00 (at the age of 71-year-old) as first dose, single for COVID-19 immunisation. The patient medical history included quadruple bypass/ coronary artery bypass in 2014, blood pressure abnormal, blood cholesterol, anxiety, supplementation therapy all from an unknown date and unknown if ongoing. Concomitant medications included Metoprolol Tartrate 25mg twice daily beta blocker prescribed after bypass surgery for her heart rate to be low in 2014, losartan 25mg daily for blood pressure and has been taking for 2-3 years. She takes it for her blood pressure due to having white coat syndrome. Atorvastatin 80mg daily into the left arm for cholesterol and has been taking for maybe 7 years, aspirin 325mg daily following bypass surgery in 2014, Bupropion XL 50mg daily for anxiety in Jun2020 and Centrum Silver Women once daily four times a week for supplement in 2020 all of which are ongoing. On 09Feb2021, the patient reported that her arm was sore the same evening of getting the first dose. It lasted through the night. It hurt if she rolled over on it. The next morning it was barely sore. She called her doctor in Jun2020 and told him she was in a funk. The doctor said everyone was having anxiety. She was prescribed Bupropion XL. She takes other vitamins but declines to provide details. No history of previous immunization with the Pfizer vaccine considered as suspect nor any additional vaccines administered on same date of the Pfizer Suspect. The patient received the second dose of the Covid-19 vaccine on 02Mar2021. The patient underwent lab test which showed weight between 200-204 lbs on Feb2021. Outcome of the event was resolved on 02Mar2021.  No follow-up attempts are possible. Information about lot/batch number cannot been obtained. No further information is expected.
Immediately bled from injection site, face got hot, flushed, and a little puffy, heart started racing, BP was taken by EMS 152/80 which is high for her. Patient was not taken to hospital, nor was any treatment given. Symptoms lasted about 30 minutes.
Information has been received from a consumer concerning her approximately 20 month old son with no pertinent medical history and no known drug reactions/allergies, who on 11-MAY-2006 was vaccinated with a dose of MMR II (Lot not reported). Concomitant therapy included DTAP and POLIO. Right around the time of vaccination, the patient experienced speech delays and was finally diagnosed with autism at 4 years of age. A lot of blood work and test had been done to the patient (results not reported). At the time of reporting, 18-MAR-2009, the patient had not recovered. The patient also, experienced rotavirus and was hospitalized. Upon internal review, autism was considered to be an other Important Medical Event. Additional information has been requested.
rash, itching tightness in chest and throat symptoms started about 45-60 min after the  vaccine. This was her 2nd covid vaccine. No symptoms with 1st vaccine
Chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 050E21A, 010M20A and 012L20A) for COVID-19 vaccination.     Concurrent medical conditions included Lung disorder NOS.   On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Aug-2021, the patient experienced CHILLS (Chills). At the time of the report, CHILLS (Chills) outcome was unknown.            Patient uses medication for cholesterol, heart condition, diabetes and high blood pressure.   No treatment information was provided.   This case was linked to MOD-2021-333507 (Patient Link).
Patient stated that they had redness and itching that seemed to be in the shape of the band-aid that was placed on their arm but now it is more diffuse to their upper arm and it is hot to the touch.
Hives spread progressively over several days across body from the site where the vaccine was administered. Arm where vaccine was administered swelled, was painful to touch and developed a fever.
Pt. called and said has a rash size about 5 inches diameter at site of injection and sore to touch. She got PREVNAR inj. 4 days ago. (Initially body ache and pain on 1st day).
PATIENT COMPLAINS ABOUT A LITTLE SWELLING AT INJECTION SITE AND SORENESS IN THE RIGHT ARM. INSTRUCTED PATIENT THAT CAN BE A RESULT OF THE VACCINE. PATIENT DID NOT HAVE FEVER OR RESPIRATORY DISTRESS AFTER CONSULTATION.
Hives after first injection 7/04: lasted about one week but not reported to us. Second injection: hives again 8/04 : no new foods soaps, detergents, etc.
Breakthrough menstrual bleeding; Heavy menstruation; Irregular menstrual cycles; This is a spontaneous report from a non-contactable reporter (consumer or other non-HCP). The reporter is the patient.  A 32-year-old female patient (not pregnant) received bnt162b2 (BNT162B2) (Lot number: unknown) at the age of 32 years as dose 2, single for COVID-19 immunisation. Relevant medical history included: "COVID-19" (unspecified if ongoing), notes: Prior to vaccination, was the patient diagnosed with COVID-19? Yes. Concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot number: UNKNOWN), for COVID-19 immunisation.  The following information was reported: INTERMENSTRUAL BLEEDING (non-serious), outcome "not recovered", described as "Breakthrough menstrual bleeding"; HEAVY MENSTRUAL BLEEDING (non-serious), outcome "not recovered", described as "Heavy menstruation"; MENSTRUATION IRREGULAR (non-serious), outcome "not recovered", described as "Irregular menstrual cycles". The events "Breakthrough menstrual bleeding", "Heavy menstruation" and "Irregular menstrual cycles" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of intermenstrual bleeding, heavy menstrual bleeding and menstruation irregular.  Additional Information: Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Treatment included unspecified treatment for the events intermenstrual bleeding, heavy menstrual bleeding and menstruation irregular. Since the vaccination, the patient had been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Appears to have broken out on rash and hives all over the body. It looks exactly like multisystem inflammatory syndrome. It has not gone down with Benadryl.
Arthritis pain intensified; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ARTHRITIS (Arthritis pain intensified) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRITIS (Arthritis pain intensified). At the time of the report, ARTHRITIS (Arthritis pain intensified) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant was reported. No treatment was reported.
Approximately 10 minutes after getting the vaccine,  patient  fainted  in the parking lot  and  bleeding on the back of his head and woke up in less than a minutes.
Rapid heartbeat, light headed, shortness of breath contine as of 10/17/21.
Itching/ Round circle at injection site; Redness at injection site; Pain at injection site (R); Hot to touch at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot to touch at injection site), VACCINATION SITE PRURITUS (Itching/ Round circle at injection site), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE PAIN (Pain at injection site (R)) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     Concurrent medical conditions included Shellfish allergy.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Hot to touch at injection site) and VACCINATION SITE PAIN (Pain at injection site (R)). On 29-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itching/ Round circle at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site). On 02-Feb-2021, VACCINATION SITE PRURITUS (Itching/ Round circle at injection site) had resolved. At the time of the report, VACCINATION SITE WARMTH (Hot to touch at injection site), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE PAIN (Pain at injection site (R)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Patient was feeling okay at the time of this report.
Service member inadvertently received smallpox and anthrax vaccinations on 6/2/04 during pregnancy.  States that she did not have a smallpox briefing but did receive educational brochures and completed the screening form.States that she had a pregnancy test on 5/25/04 but did not receive the results until 6/3/04.  States that she had to go to a different base to have the pregnancy test done and sometimes the results take longer to get back.States that she did not have any problems with the vaccinations up to this point.  Denies any rashes, flu-like symptoms, pruritus, chest pain, and shortness of breath or fever. No numbness or tingling in extremities.  No lesions other than SPV site. Referred to OB provider.  Scheduled to be seen on 6/7/04.